Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
30.9M
-
Shares change
-
+517K
-
Total reported value, excl. options
-
$1.03B
-
Value change
-
+$25M
-
Put/Call ratio
-
0.69
-
Number of buys
-
125
-
Number of sells
-
-43
-
Price
-
$33.15
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q1 2018
219 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q1 2018.
Editas Medicine, Inc. - Common Stock (EDIT) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.9M shares
of 82.8M outstanding shares and own 37.38% of the company stock.
Largest 10 shareholders include FMR LLC (4.04M shares), VANGUARD GROUP INC (3.02M shares), BlackRock Inc. (2.86M shares), STATE STREET CORP (2.39M shares), Capital World Investors (2.18M shares), MORGAN STANLEY (1.88M shares), ARK Investment Management LLC (1.62M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.16M shares), Viking Global Investors LP (1.04M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (892K shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.